{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:09:47Z","timestamp":1769105387536,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ijid.2014.01.026","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T05:07:13Z","timestamp":1404277633000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Unanticipated Mycobacterium tuberculosis complex culture inhibition by immune modulators, immune suppressants, a growth enhancer, and vitamins A and D: clinical implications"],"prefix":"10.1016","volume":"26","author":[{"given":"Robert J.","family":"Greenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.01.026_bib0005","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jis460","article-title":"World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?","volume":"207","author":"Dooley","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"19","author":"Klopper","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMra1205429","article-title":"Tuberculosis, drug resistance, and the history of modern medicine","volume":"367","author":"Keshavjee","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.01.026_bib0020","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.00120-13","article-title":"WHO Group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis","volume":"57","author":"Chang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1473-3099(12)70293-1","article-title":"A comprehensive regulatory framework to address the unmet need for new antibacterial treatments","volume":"13","author":"Rex","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0030","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/AAC.01277-13","article-title":"The FDA reboot of antibiotic development","volume":"57","author":"Shlaes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMp1215093","article-title":"The future of antibiotics and resistance","volume":"368","author":"Spellberg","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.01.026_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/472032a","article-title":"Fix the antibiotics pipeline","volume":"472","author":"Cooper","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2014.01.026_bib0045","unstructured":"Rouse D. Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF). Research Triangle Park, NC: RTI International; 2006. Available at: http:\/\/www.taacf.org (accessed January 2007)."},{"key":"10.1016\/j.ijid.2014.01.026_bib0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/187152607781001790","article-title":"Programs to facilitate tuberculosis drug discovery: the tuberculosis antimicrobial acquisition and coordinating facility","volume":"7","author":"Goldman","year":"2007","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.ijid.2014.01.026_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/187152607781001844","article-title":"The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control","volume":"7","author":"Goldman","year":"2007","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.ijid.2014.01.026_bib0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(04)16781-0","article-title":"Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?","volume":"364","author":"Greenstein","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0065","series-title":"Sequelae and long-term consequences of infectious diseases.","first-page":"135","article-title":"Leprosy, a battle turned; tuberculosis, a battle raging; paratuberculosis, a battle ignored","author":"Greenstein","year":"2009"},{"key":"10.1016\/j.ijid.2014.01.026_bib0070","first-page":"1447","article-title":"Genomewide association study of leprosy","volume":"362","author":"Greenstein","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.01.026_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(03)00724-2","article-title":"Is Crohn's disease caused by a Mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease","volume":"3","author":"Greenstein","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0954-6820.1942.tb06841.x","article-title":"Salazopyrin, a new sulfanilamide preparation. A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulfanilamide preparations","volume":"110","author":"Svartz","year":"1942","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ijid.2014.01.026_bib0085","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1371\/journal.pone.0000161","article-title":"On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis","volume":"2","author":"Greenstein","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.01.026_bib0090","doi-asserted-by":"crossref","first-page":"e2496","DOI":"10.1371\/journal.pone.0002496","article-title":"On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis","volume":"3","author":"Greenstein","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.01.026_bib0095","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/j.ijid.2008.10.016","article-title":"On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture","volume":"13","author":"Greenstein","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0100","doi-asserted-by":"crossref","first-page":"e11099","DOI":"10.1371\/journal.pone.0011099","article-title":"The thioamides methimazole and thiourea inhibit growth of M. avium subspecies paratuberculosis in culture","volume":"5","author":"Greenstein","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.01.026_bib0105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.00678-07","article-title":"Thiopurine drugs (azathioprine and 6-mercaptopurine) inhibit Mycobacterium paratuberculosis growth in vitro","volume":"52","author":"Shin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0110","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jac\/dkp339","article-title":"Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis","volume":"64","author":"Krishnan","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0115","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1371\/journal.pone.0000516","article-title":"On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis","volume":"2","author":"Greenstein","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.01.026_bib0120","doi-asserted-by":"crossref","first-page":"e29631","DOI":"10.1371\/journal.pone.0029631","article-title":"and D inhibit the growth of mycobacteria in radiometric culture","volume":"7","author":"Greenstein","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.01.026_bib0125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10620-010-1301-7","article-title":"Growth of M. avium subspecies paratuberculosis in culture is enhanced by nicotinic acid, nicotinamide, and \u03b1 and \u03b2 nicotinamide adenine dinucleotide","volume":"56","author":"Greenstein","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijid.2014.01.026_bib0130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1378\/chest.12.5.409","article-title":"its bactericidal action","volume":"12","author":"Raab","year":"1946","journal-title":"Diseases of the Chest"},{"key":"10.1016\/j.ijid.2014.01.026_bib0135","doi-asserted-by":"crossref","first-page":"e2375","DOI":"10.1371\/journal.pone.0002375","article-title":"Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv","volume":"3","author":"Zheng","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2014.01.026_bib0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.24.3.357-363.1986","article-title":"Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease","volume":"24","author":"Chiodini","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(04)17058-X","article-title":"Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease","volume":"364","author":"Naser","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1757-4749-1-4","article-title":"Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture","volume":"1","author":"Greenstein","year":"2009","journal-title":"Gut Pathog"},{"key":"10.1016\/j.ijid.2014.01.026_bib0155","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/JCM.13.5.908-912.1981","article-title":"Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis","volume":"13","author":"Siddiqi","year":"1981","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0160","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","article-title":"Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials","volume":"44","author":"Rusch-Gerdes","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jac\/dkp184","article-title":"Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs","volume":"64","author":"Krishnan","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-1135(90)90122-C","article-title":"Growth of Mycobacterium paratuberculosis in radiometric, Middlebrook and egg-based media","volume":"22","author":"Damato","year":"1990","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0175","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"363","author":"Britton","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0180","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1128\/AAC.36.12.2843","article-title":"Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol","volume":"36","author":"Rastogi","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0185","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.dld.2007.01.008","article-title":"Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars","volume":"39","author":"Borody","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1590-8658(02)80056-1","article-title":"Treatment of severe Crohn's disease using antimycobacterial triple therapy\u2014approaching a cure?","volume":"34","author":"Borody","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0195","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","article-title":"Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease","volume":"132","author":"Selby","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijid.2014.01.026_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(46)91185-3","article-title":"Para-aminosalicylic acid in the treatment of tuberculosis","volume":"1","author":"Lehmann","year":"1946","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0205","first-page":"769","article-title":"[Bactericidal action of isoniazid (isonicotinic acid hydrazide) on Mycobacterium tuberculosis]","volume":"83","author":"Noufflard","year":"1952","journal-title":"Ann Inst Pasteur (Paris)"},{"key":"10.1016\/j.ijid.2014.01.026_bib0210","first-page":"580","article-title":"Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs","volume":"2","author":"Abate","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2165\/00003088-199732020-00004","article-title":"Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes","volume":"32","author":"Peloquin","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0220","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0225","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.40.7.1610","article-title":"In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis","volume":"40","author":"Rastogi","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002849900095","article-title":"In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages","volume":"33","author":"Rastogi","year":"1996","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0235","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1128\/JCM.00688-10","article-title":"Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar","volume":"48","author":"Satana","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0415","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1469-0691.2011.03716.x","article-title":"Clofazimine in the treatment of multidrug-resistant tuberculosis","volume":"18","author":"Xu","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2014.01.026_bib0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis","volume":"56","author":"Fortun","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/648675","article-title":"Linezolid in the treatment of multidrug-resistant tuberculosis","volume":"50","author":"Schecter","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0255","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.5588\/ijtld.12.0144","article-title":"Systematic review of clofazimine for the treatment of drug-resistant tuberculosis","volume":"17","author":"Gopal","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jac\/dks389","article-title":"Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"68","author":"Dey","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkr444","article-title":"current status and future prospects","volume":"67","author":"Cholo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.01.026_bib0270","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A: a new antilymphocytic agent","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"10.1016\/j.ijid.2014.01.026_bib0275","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijid.2014.01.026_bib0280","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijid.2014.01.026_bib0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(00)00186-7","article-title":"Immunosuppressive drugs: the first 50 years and a glance forward","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ijid.2014.01.026_bib0290","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.01.026_bib0295","first-page":"349","article-title":"Monensin, a new biologically active compound. I. Discovery and isolation","volume":"7","author":"Haney","year":"1967","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"10.1016\/j.ijid.2014.01.026_bib0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.rvsc.2006.09.009","article-title":"Pre-partum monensin supplementation improves body reserves at calving and milk yield in Holstein cows dried-off with low body condition score","volume":"82","author":"Melendez","year":"2007","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.ijid.2014.01.026_bib0305","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.3168\/jds.S0022-0302(06)72530-9","article-title":"Effects of rumen-protected choline and monensin on milk production and metabolism of periparturient dairy cows","volume":"89","author":"Zahra","year":"2006","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.ijid.2014.01.026_bib0310","first-page":"369","article-title":"Monensin, a new biologically active compound. VI. Anticoccidial activity","volume":"7","author":"Shumard","year":"1967","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"10.1016\/j.ijid.2014.01.026_bib0315","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.prevetmed.2006.03.001","article-title":"Efficacy of monensin sodium for the reduction of fecal shedding of Mycobacterium avium subsp. paratuberculosis in infected dairy cattle","volume":"75","author":"Hendrick","year":"2006","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.ijid.2014.01.026_bib0320","first-page":"175","article-title":"Susceptibility of Mycobacterium avium sbsp paratuberculosis to monensin sodium or tilmicosin phosphate in vitro and resulting infectivity in a murine model","volume":"68","author":"Brumbaugh","year":"2004","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.ijid.2014.01.026_bib0325","unstructured":"World Health Organization. Evaluation of certain veterinary drug residues in food. World Health Organ Tech Rep Ser 2012;(969):i\u2013vii, 1-101."},{"key":"10.1016\/j.ijid.2014.01.026_bib0330","first-page":"180","article-title":"Milk residues and performance of lactating dairy cows administered high doses of monensin","volume":"69","author":"Bagg","year":"2005","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.ijid.2014.01.026_bib0335","first-page":"43","article-title":"Ionophores: their use as ruminant growth promotants and impact on food safety","volume":"4","author":"Callaway","year":"2003","journal-title":"Curr Issues Intest Microbiol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0340","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.taap.2010.12.014","article-title":"Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects","volume":"270","author":"Dorne","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0345","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BC20050003","article-title":"Cytochrome P450 expression\u2013induction profile and chemically mediated alterations of the WIF-B9 cell line","volume":"98","author":"Biagini","year":"2006","journal-title":"Biol Cell"},{"key":"10.1016\/j.ijid.2014.01.026_bib0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-121768","article-title":"Downregulation of AbetaPP enhances both calcium content of endoplasmic reticulum and acidic stores and the dynamics of store operated calcium channel activity","volume":"34","author":"Chatzistavraki","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0355","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/dmd.112.050054","article-title":"Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)","volume":"41","author":"Kazmi","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijid.2014.01.026_bib0360","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3892\/or.2013.2308","article-title":"Cyclooxygenase-2 is induced by p38 MAPK and promotes cell survival","volume":"29","author":"Parente","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijid.2014.01.026_bib0365","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.bpj.2013.03.019","article-title":"Stoichiometric relationship between Na(+) ions transported and glucose consumed in human erythrocytes: Bayesian analysis of (23)Na and (13)C NMR time course data","volume":"104","author":"Puckeridge","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.ijid.2014.01.026_bib0370","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1053\/ajkd.2001.28618","article-title":"Rhabdomyolysis, acute renal failure, and death after monensin ingestion","volume":"38","author":"Caldeira","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijid.2014.01.026_bib0375","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2134\/jeq2003.1591","article-title":"Potential environmental benefits of ionophores in ruminant diets","volume":"32","author":"Tedeschi","year":"2003","journal-title":"J Environ Qual"},{"key":"10.1016\/j.ijid.2014.01.026_bib0380","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3382\/ps.0552442","article-title":"Anticoccidial action of monensin in turkey poults","volume":"55","author":"McDougald","year":"1976","journal-title":"Poult Sci"},{"key":"10.1016\/j.ijid.2014.01.026_bib0385","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(10)61889-2","article-title":"High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial","volume":"377","author":"Martineau","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0390","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(99)02301-6","article-title":"Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case\u2013control study","volume":"355","author":"Wilkinson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2014.01.026_bib0395","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1073\/pnas.1200072109","article-title":"Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment","volume":"109","author":"Coussens","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2014.01.026_bib0400","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3168\/jds.2012-5929","article-title":"Cow-level association between serum 25-hydroxyvitamin D concentration and Mycobacterium avium subspecies paratuberculosis antibody seropositivity: a pilot study","volume":"96","author":"Sorge","year":"2013","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.ijid.2014.01.026_bib0405","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-2427(95)05484-7","article-title":"Low calcium diet and 1,25-dihydroxyvitamin D(3) infusion modulate immune responses during Mycobacterium paratuberculosis infection in beige mice","volume":"50","author":"Stabel","year":"1996","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.ijid.2014.01.026_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-386960-9.00001-0","article-title":"regulation of immune function","volume":"86","author":"Bikle","year":"2011","journal-title":"Vitam Horm"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214014349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214014349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T21:38:48Z","timestamp":1598045928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214014349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":82,"alternative-id":["S1201971214014349"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.01.026","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unanticipated Mycobacterium tuberculosis complex culture inhibition by immune modulators, immune suppressants, a growth enhancer, and vitamins A and D: clinical implications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}